BRCA1 and TP53 Gene-Mutations: Family Predisposition and Radioecological Risk of Developing Breast Cancer

  • Published : 2016.08.01


Frequencies of polymorphisms of genes BRCA1 and ТР53 in breast cancer (BC) patients with a BC family history and radiation history were assessed and compared in the Semey region of Kazakhstan. The study included 60 women directly irradiated by the activities of the Semipalatinsk test site with a calculated effective equivalent dose of 500 mSv and their first generation descendants (group BC+Her+Exp); 65 women with family BC and absence of radiological history - the effective equivalent dose due to anthropogenic sources not exceeding 50 mSv (group BC+Her-Exp). The comparison group consisted of 65 women patients with breast cancer without family and radiological history (BC-Her-Exp). The control group comprised 60 women without breast cancer and without family and radiological history (nonBC). We carried out the genotyping of the polymorphisms c.2311T>C, c.4308T>C and 5382insC of the BRCA1 gene and rs1042522 of the ТР53 gene. The frequency of the polymorphism c.2311T>C was significantly higher in patients of the group BC+Her+Exp than in healthy women, and of the polymorphism 5382insC in BC+Her+Exp compared to all other groups. The frequency of the rs1042522 polymorphism of ТР53 was significantly higher in all groups of patients with breast cancer compared with the control group. Differences between groups of women with breast cancer were significant only in BC+Her+Exp vs. BC+Her-Exp. Combinations of polymorphisms of the genes BRCA1 and TP53 predominated in women with a family and radiological history.


  1. Apsalikov BA, Manambaieva ZA, Belikhina TI, et al (2016). The dynamics of morbidity of breast cancer in the Eastern- Kazakhstanskaia Oblast and role of radiation factor. The Journal of Problems of Social Hygiene, Public Health and History of Medicine, 24, 7-10.
  2. Aune D, Keum N, Giovannucci E, et al (2016). Whole grain consumption and the risk of cardiovascular disease, cancer, and all-cause and cause-specific mortality-a systematic review and dose-response meta-analysis of prospective studies. BMJ, 353, 1-14.
  3. Azim HA, Partridge AH (2014). Biology of breast cancer in young women. Breast Cancer, 16, 427.
  4. Bauer S, Gusev BI, Pivina LM, et al (2006). Esophagus cancer and radiation exposure due to nuclear test fallout: an analysis based on the data of the Semipalatinsk historical cohort, 1960-1999. Radiats Biol Radioecol, 46, 611-628.
  5. Berrington de Gonzalez A, Gilbert E, Curtis R, et al (2013). Second solid cancers after radiation therapy: a systematic review of the epidemiologic studies of the radiation doseresponse relationship. Int J Radiat Oncol Biol Phys, 86, 224-33.
  6. Boyd J (2014). Genetic predisposition to breast cancer. Cancer, 7, 932-934.
  7. Couch FJ, Nathanson KL, Offit K (2014). Two decades after BRCA: setting paradigms in personalized cancer care and prevention. Science, 6178, 1466-70.
  8. Galluzzi L, Pietrocola F, Bravo-San Pedro JM, et al (2015). Autophagy in malignant transformation and cancer progression. EMBO J, 7, 856-80.
  9. Hughes CK, Tsark JU, Kenni CK, et al (2000). Cancer research studies in native Hawaiians and pacific islanders. Ann Epidemiol, 10, 49-60.
  10. Kleibl Z, Kristensen VN (2016). Women at high risk of breast cancer: Molecular characteristics, clinical presentation and management. Breast, 28, 136-44.
  11. Kuchenbaecker KB, Ramus SJ, Tyrer J, et al (2015). Identification of six new susceptibility loci for invasive epithelial ovarian cancer. Nature Genetics, 2, 164-171.
  12. Malhotra J, Malvezzi M, Negri E, et al (2016). Risk factors for lung cancer worldwide. Eur Respiratory J, 359.
  13. Mangano JJ, Sherman JD (2011). Elevated in vivo strontium-90 from nuclear weapons test fallout among cancer decedents: a case-control study of deciduous teeth. Int J Health Serv, 41, 137-58.
  14. Mark A Wade, Felicity EB May, Ken Onel (2016). Does radiation-induced c-MYC amplification initiate breast oncogenesis? Molecular Cellular Oncol, 3, 1-3.
  15. Mckenna Longacre, Nicole A Snyder, Genevieve Housman, et al (2016). Comparative analysis of genetic and epigenetic events of breast and ovarian cancer related to tumorigenesis. Int J Molekular Sci, 17, 759.
  16. Nichols KE, Heath JA, Friedman D, et al (2003). TP53, BRCA1, and BRCA2 tumor suppressor genes are not commonly mutated in survivors of Hodgkin's disease with second primary neoplasms. J Clin Oncol, 24, 4505.
  17. Polakova V, Pardini B, Naccarati A, et al (2009). Genotype and haplotype analysis of cell cycle genes in sporadic colorectal cancer in the Czech Republic. Hum Mutat, 30, 661-8.
  18. Preston DL, Ron E, Tokuoka S, et al (2007). Solid cancer incidence in atomic bomb survivors: 1958-1998. Radiat Res, 168, 1-64.
  19. Sana M, Malik HJ (2015). Current and emerging breast cancer biomarkers. J Cancer Res Therapeutics, 3, 508.
  20. Wade MA, Sunter NJ, Fordham SE, et al (2015). c-MYC is a radiosensitive locus in human breast cells. Oncogene, 34, 4985-94.
  21. Wijnen M, Heuvel-Eibrink MM, Medici M, et al (2016). The role of early life exposures on subsequent cancer risk. Endocr Relat Cancer, 23, 299-321.